Biomateriale - Proteze
Biomateriale - Proteze
Biomateriale - Proteze
Chapter 1
INTRODUCTION
1.1 Biomaterials
1
February 27, 2004 11:40 WSPC/Book Trim Size for 9in x 6in chap01
2 AN INTRODUCTION TO BIOCOMPOSITES
Introduction 3
Table 1.1 Various factors of importance in material selection for biomedical applications
[Ramakrishna et al., 2001].
Factors Description
Chemical/Biological Physical Mechanical/Structural
Characteristics Characteristics Characteristics
1st Level Material chemical density elastic modulus
Properties composition shear modulus
(bulk and surface) Poissons ratio
yield strength
tensile strength
compressive
strength
2nd Level Material adhesion surface hardness
Properties topology flexural modulus
texture flexural strength
roughness
Specific Functional biofunctionality form & stiffness or
Requirements bioinert geometry rigidity
(based on bioactive coefficient of fracture toughness
application) biostability thermal fatigue strength
biodegradation expansion creep resistance
behavior electrical friction and wear
conductivity resistance
color, adhesion strength
aesthetics impact strength
refractive proof stress
index abrasion
opacity or resistance
translucency
Processing & reproducibility, quality, sterilizability, packaging, secondary
Fabrication processability
Characteristics of host: tissue, organ, species, age, sex, race, health condition, activity,
systemic response
Medical/surgical procedure, period of application/usage
Cost
are their high stiffness compared to host tissues as well as their tendency to
create severe imaging artifacts in the most advanced diagnostic 3-D imaging
procedures i.e. X-ray Computer Tomography (CT) and nuclear Magnetic
Resonance Imaging (MRI). Stainless steel and cobalt-chromium alloys are
sensitive to corrosion, thus releasing metal ions which may cause allergic
February 27, 2004 11:40 WSPC/Book Trim Size for 9in x 6in chap01
4 AN INTRODUCTION TO BIOCOMPOSITES
Composites are those materials that contain two or more distinct constituent
phases, on a scale larger than the atomic. The term biocomposites spe-
cially refers to those composites that can be employed in bioengineering.
The constituents retain their identities in the composite. Namely, they do not
dissolve or otherwise merge completely into each other although they act
in concert. Normally, the constituent components can be physically identi-
fied and exhibit an interface between one another. In composites, properties
such as the elastic modulus can be significantly different from those of the
constituents alone but are considerably altered by the constituent structures
and contents. From a structural point of view, composites are anisotropic
in nature. Their mechanical properties are different in different directions.
Most of the living tissues such as bone, dentin, collagen, cartilage, and skin
are essentially composites. Those natural biocomposites are not discussed in
this book, but the reader can refer to, e.g. [D. Taylor, 2003]. Synthetic com-
posites are essentially a combination of two constituent phases, i.e. a rein-
forcing phase such as fiber or particle and a continuous phase called matrix.
The primary motive in the development of biocomposites is that by vary-
ing the type and distribution of the reinforcing phases in the composites it is
possible to obtain a wide range of mechanical and biological properties, and
hence to optimize the structure and performance of the biomedical devices
and their interaction with the surrounding tissues. A schematic diagram
to show potential use of biocomposites in the repair, reconstruction, and
replacement of human hard tissues is given in Fig. 1.1. A number of polymer
February 27, 2004 11:40 WSPC/Book Trim Size for 9in x 6in chap01
Introduction 5
Cartilage Replacement
PET/PU, PTFE/PU, CF/PTFE
CF/C
Total Knee Replacement
CF/UHMWPE, UHMWPE/
Boneplates & Screws UHMWPE
CF/PEEK, CF/Epoxy,
CF/PMMA
CF/PP, CF/PS, CF/PLLA,
CF/PLA, KF/PC, HA/PE,
PLLA/PLDLA, PGA/PGA
External Fixation
CF/Epoxy
CF: Carbon fibers, C: Carbon, GF: Glass fibers, KF: Kevlar fibers, PMMA: Polymethymethacrylate,
PS: Polysulfone, PP: Polypropylene, UHMWPE: Ultra-high-molecular weight polyethylene,
PLDLA: Poly(L-DL-lactide), PLLA: Poly (L-lactic acid), PGA: Polyglycolic acid, PC: Polycarbonate,
PEEK: Polyetheretheketone; HA: Hydroxyapatite, PMA: Polymethylacrylate,
BIS-GMA: bis-phenol A glycidyl methacrylate, PU: Polyurethane, PTFE: polytetrafluoroethylene,
PET: polyethyleneterephthalate, PEA: poltethylacrylate, SR: silicone rubber,
PELA: Block co-polymer of lactic acid and polyethylene glycol, LCP: liquid crystalline polymer,
PHB: Polyhydroxybutyrate, PEG: polyethyleneglycol,
PHEMA: poly(20hydroxyethyl methacrylate)
6 AN INTRODUCTION TO BIOCOMPOSITES
Table 1.2 Mechanical properties of hard tissues, representative values only, note that
tissues show broad variation [Black and Hastings, 1998].
Table 1.3 Mechanical properties of soft tissues, representative values only, note that tissues
show broad variation [Black and Hastings, 1998].
Introduction 7
8 AN INTRODUCTION TO BIOCOMPOSITES
Introduction 9
Biocomposites
2D composites 3D composites
10 AN INTRODUCTION TO BIOCOMPOSITES
A
B
C
E
F
Fig. 1.3 Endless carbon fiber reinforced PEEK matrix medical screws made by Composite
Flow Molding, carbon fiber volume content 62% (by courtesy of Icotec AG, Switzerland)
[R. Tognini, Ph.D. Thesis, ETH Zurich, 2001].
Fig. 1.4 Hip endoprosthesis stem, injection molded, chopped long fiber reinforced PEEK,
fiber volume content 50% [M. Semadeni, Ph.D. Thesis, ETH Zurich, 1999].
Introduction 11
Fig. 1.5 Carbon fiber reinforced epoxy composite bone plates (Evans and Gregson, Bio-
materials, Vol. 19, No. 15, pp. 13291342, 1998).
completely. This would cause the patient additional risk, pain and expen-
diture. Such an operation can be avoided if a fully resorbable fixator is
used. Most work in the literature on fully resorbable biocomposite fracture
fixators has been done based on the group of PLA (polylactic acid) poly-
mers. The reason is that PLAs possess two major characteristics that make
them an extremely attractive bioabsorbable material [Alexander, 1996]:
(1) they can degrade inside the body in a rate that can be controlled, e.g. by
varying molecular weight, the share of their enantiomers L and D-lactide
or copolymerising it with PGA (polyglycolic acid) polymer, and (2) and, if
crystallization of the PLA-polymer is prevented, their degradation products
are nontoxic, biocompatible, and easily metabolized. The main problem of
those composites is the coordination of the degradation behavior of both
phases and, especially, of the interphase between both.
Partially resorbable biocomposites have been fabricated using
non-absorbable reinforcing materials and absorbable matrix materials.
Historically, they have been the predecessors of the fully degradable com-
posites. However, due to severe inflammatory tissue reactions on the remain-
ing, non-degradable phase, most of the research on these materials has
been stopped. They have been investigated for a number of medical appli-
cations such as bone replacements, bone cements and also internal frac-
ture fixators. Particulate reinforced materials which have been practiced
include PMMA (polymethylmethacrylate) and PBT (poly(butylene tereph-
thalate)) as non-resorbable matrics in combination with HA or PLAs,
February 27, 2004 11:40 WSPC/Book Trim Size for 9in x 6in chap01
12 AN INTRODUCTION TO BIOCOMPOSITES
Introduction 13
14 AN INTRODUCTION TO BIOCOMPOSITES
Introduction 15
The third major issue addressed in the book is the design and devel-
opment examples of several medical devices and implants using polymer
composites. These devices are supposed to be used for hard tissue appli-
cations, including Prosthetic socket, Dental post, External fixator, Bone
plate, Orthodontic archwire, Orthodontic bracket, Total hip replacement,
and Composite screws and pins. Fabrication and mechanical testing of
them have been shown, with comparisons with other clinically used med-
ical devices if possible. Among them, some devices such as bone plate
and archwire are primary load carrying elements. Their ultimate strength
behavior must be targeted during the design. It is noted that both of them are
mainly subjected to lateral loading (bending) in their clinical application.
According to current understanding, the estimation of composite bending
strength remains a challenge. In this book, design procedures for those med-
ical devices using continuous fiber reinforced polymer matrix composites
are described in sufficient detail. We believe that comparable procedures
can be followed if other critical designs are to be made.
References
16 AN INTRODUCTION TO BIOCOMPOSITES
Introduction 17